OREXIGEN THERAPEUTICS, INC. EXCHANGE AGREEMENTExchange Agreement • December 1st, 2017 • Orexigen Therapeutics, Inc. • Pharmaceutical preparations
[Name of Holder] (the “Holder”) enters into this Exchange Agreement (the “Agreement”) with Orexigen Therapeutics, Inc., a Delaware corporation (the “Company”) as of the date first written above whereby the Holder will exchange (the “Exchange”) the Outstanding Notes (as defined below) for shares of the Company’s common stock, par value $0.001 (the “Common Stock”).
